August 11th 2021 3:00 pm IST
Webinar: Accelerate the pace of pharma innovation with Clarivate’s research intelligence tools
Loading...
Getting a new drug to market as quickly as possible is a key focus for any pharmaceutical company, regardless of size. Along with maintaining speed in the development process, pharma researchers must also ensure thoroughness and quality of the data they use to make the right decisions at every stage of development.
With high quality, rigorously curated scientific information, Clarivate tools like the Web of Science platform help identify emerging and current research trends, engage with relevant external experts, and monitor competitor activity.
Being able to do these tasks efficiently and effectively with reliable and trustworthy information will accelerate a company’s drug development program, reduce drugs failure rates and keep it one step ahead of competition.
With high quality, rigorously curated scientific information, Clarivate tools like the Web of Science platform help identify emerging and current research trends, engage with relevant external experts, and monitor competitor activity.
Being able to do these tasks efficiently and effectively with reliable and trustworthy information will accelerate a company’s drug development program, reduce drugs failure rates and keep it one step ahead of competition.
We will be covering the following topics:
-
Harnessing the power of citations to identify the right research
-
Track emerging research trends in biomedical sciences
-
Gain insights into millions of novel compounds and reaction schema
-
Analyse research impact of your organization
-
Map competition and its research portfolio and network
-
Thought Leader Identification in each research area
-
Research Funding Analysis
-
Reference management-Storage and Retrieval
Our talented speakers cover research, innovation and intellectual property
Dr. Subhasree Nag
Regional Solutions Consultant
Clarivate
Clarivate
Dr. Subhasree Nag is a regional solutions consultant for the life sciences and scholarly research division at Clarivate. She completed her PhD from Texas Tech University Health Sciences Center, USA and her post-doctoral training from Pacific Northwest National Laboratory, USA. A pharmacologist and toxicologist by training, she has more than 8 years of research experience in anticancer drug discovery, preclinical pharmacology, and systems biology areas with 27 peer reviewed publications and more than 1,000 citations.